Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

InVivo Therapeutics Holdings Corp (NASDAQ:NVIV)

1.95
Delayed Data
As of May 26
 -0.05 / -2.50%
Today’s Change
1.95
Today|||52-Week Range
7.94
-53.57%
Year-to-Date
No recent news for InVivo Therapeutics Holdings Corp.

Today’s Trading

Previous close2.00
Today’s open2.00
Day’s range1.95 - 2.05
Volume210,442
Average volume (3 months)225,647
Market cap$62.7M
Dividend yield--
Data as of 05/26/2017

Growth & Valuation

Earnings growth (last year)+39.68%
Earnings growth (this year)+2.56%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book2.16

Competitors

 Today’s
change
Today’s
% change
KMPHKemPharm Inc+0.05+1.19%
LPTXLeap Therapeutics In...-0.18-2.59%
SRRASierra Oncology Inc+0.02+1.67%
SNESSenesTech Inc-0.33-4.82%
Data as of 05/26/2017

Financials

Next reporting dateAugust 4, 2017
EPS forecast (this quarter)-$0.18
Annual revenue (last year)$0.00
Annual profit (last year)-$23.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Mark D. Perrin
Senior Vice President-
Operations
William D'Agostino
Corporate headquarters
Cambridge, Massachusetts

Forecasts